HAVANA A Cuban Scientific Research Institute just patented a promising new drug that it says helps terminal lung cancer patients live longer. In some cases, the drug known as CimaVax EGF extended the lives of participants in the treatment trials by close to a year. CimaVax EGF, is classified as a therapeutic vaccine, because it is composed of modified proteins that help the body ...


